NO921236L - Fremgangsmaate for enzymatisk fremstilling av basisk fibroblastfaktor - Google Patents

Fremgangsmaate for enzymatisk fremstilling av basisk fibroblastfaktor

Info

Publication number
NO921236L
NO921236L NO92921236A NO921236A NO921236L NO 921236 L NO921236 L NO 921236L NO 92921236 A NO92921236 A NO 92921236A NO 921236 A NO921236 A NO 921236A NO 921236 L NO921236 L NO 921236L
Authority
NO
Norway
Prior art keywords
bfgf
thr
procedure
adduct
basic fibroblast
Prior art date
Application number
NO92921236A
Other languages
English (en)
Other versions
NO301480B1 (no
NO921236D0 (no
Inventor
Pierre Monsan
Francois Paul
Didier Betbeder
Paolo Sarmientos
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NO921236L publication Critical patent/NO921236L/no
Publication of NO921236D0 publication Critical patent/NO921236D0/no
Publication of NO301480B1 publication Critical patent/NO301480B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
NO921236A 1990-08-02 1992-03-30 Fremgangsmåte for enzymatisk fremstilling av basisk fibroblastfaktor NO301480B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909017008A GB9017008D0 (en) 1990-08-02 1990-08-02 Process for the enzymatic preparation of basic fibroblast growth factor
PCT/EP1991/001428 WO1992002539A1 (en) 1990-08-02 1991-07-30 Process for the enzymatic preparation of basic fibroblast growth factor

Publications (3)

Publication Number Publication Date
NO921236L true NO921236L (no) 1992-03-30
NO921236D0 NO921236D0 (no) 1992-03-30
NO301480B1 NO301480B1 (no) 1997-11-03

Family

ID=10680087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921236A NO301480B1 (no) 1990-08-02 1992-03-30 Fremgangsmåte for enzymatisk fremstilling av basisk fibroblastfaktor

Country Status (27)

Country Link
US (1) US5348863A (no)
EP (1) EP0495049B1 (no)
JP (1) JPH05501655A (no)
KR (1) KR100191697B1 (no)
CN (1) CN1033810C (no)
AT (1) ATE152122T1 (no)
AU (1) AU643822B2 (no)
CA (1) CA2066174A1 (no)
CZ (1) CZ286237B6 (no)
DE (1) DE69125810T2 (no)
DK (1) DK0495049T3 (no)
ES (1) ES2103822T3 (no)
FI (1) FI921428A0 (no)
GB (1) GB9017008D0 (no)
GR (1) GR3024111T3 (no)
HU (1) HU212671B (no)
IE (1) IE912729A1 (no)
IL (1) IL98988A (no)
MY (1) MY107334A (no)
NO (1) NO301480B1 (no)
NZ (1) NZ239204A (no)
PH (1) PH31240A (no)
PT (1) PT98544B (no)
RU (1) RU2093519C1 (no)
WO (1) WO1992002539A1 (no)
YU (1) YU48309B (no)
ZA (1) ZA916026B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67217A (en) * 1992-02-14 1995-03-28 Kaken Pharma Co Ltd Remedy for airway diseases
HU221638B1 (hu) * 1994-04-21 2002-12-28 Leukotech A/S Heparinkötő fehérje alkalmazása szepszis kezelésére szolgáló gyógyszer előállítására
US5939390A (en) * 1995-03-09 1999-08-17 Novo Nordisk A/S Pharmaceutical composition
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
RU2187118C2 (ru) * 2000-07-13 2002-08-10 Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова Способ диагностики возможности рецидивов церебральных рацемозных артериовенозных мальформаций
IL141647A0 (en) 2001-02-26 2002-03-10 Yeda Res & Dev Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
ATE512674T1 (de) 2003-01-06 2011-07-15 Angiochem Inc Angiopep-1, verwandte verbindungen, und deren verwnedungen
NZ541659A (en) 2003-01-14 2007-05-31 Teva Pharma Pharmaceutical composition comprising with a pH between 4 and 9 to treat SLE comprising an aqueous carrier, a pharmaceutically acceptable salt of a peptide and a substituted beta-cyclodextrin
US8618054B2 (en) 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
EP1751175B1 (en) 2004-05-05 2012-07-25 VALORISATION-RECHERCHE, Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
AU2006264567A1 (en) 2005-05-05 2007-01-11 Valorisation Hsj, Societe En Commandite Cytokine receptor modulators and uses thereof
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CA2688344C (en) 2007-05-29 2019-09-03 Angiochem, Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CN102026667B (zh) 2008-04-18 2014-06-25 安吉奥开米公司 紫杉醇、紫杉醇类似物或紫杉醇结合物的药物组合物及相关制备方法和用途
US8828925B2 (en) 2008-10-15 2014-09-09 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
WO2010063122A1 (en) 2008-12-05 2010-06-10 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
EP2373789A4 (en) 2008-12-17 2012-08-29 Angiochem Inc MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
RU2011146654A (ru) 2009-04-20 2013-05-27 Ангиокем Инк. Способы лечения рака яичников с применением конъюгированного средства
WO2011000095A1 (en) 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
EP2588490B1 (en) 2010-07-02 2017-02-22 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
SG11201509430WA (en) * 2013-05-16 2015-12-30 Agency Science Tech & Res Heparan sulphates
WO2016080916A1 (en) 2014-11-19 2016-05-26 Agency For Science, Technology And Research Heparan sulphates for use in repair and/or regeneration of skin
WO2016080915A1 (en) 2014-11-19 2016-05-26 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
CN105294851B (zh) * 2015-12-07 2019-02-12 中国科学院长春应用化学研究所 与几丁质特异结合的碱性成纤维细胞生长因子及其编码基因、制备方法与应用
CN114965839A (zh) * 2022-05-11 2022-08-30 朗肽生物制药股份有限公司 人碱性成纤维细胞生长因子的肽图分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
DE3811921A1 (de) * 1988-04-09 1989-10-19 Hoechst Ag Verfahren zur herstellung von proteinen, die n-terminal mit prolin beginnen
US5136025A (en) * 1990-04-04 1992-08-04 California Biotechnology Inc. Method to purify basic fibroblast growth factor

Also Published As

Publication number Publication date
AU643822B2 (en) 1993-11-25
CN1058597A (zh) 1992-02-12
ES2103822T3 (es) 1997-10-01
PT98544B (pt) 1999-01-29
US5348863A (en) 1994-09-20
YU48309B (sh) 1998-05-15
PH31240A (en) 1998-06-18
JPH05501655A (ja) 1993-04-02
GB9017008D0 (en) 1990-09-19
HU9201101D0 (en) 1992-08-28
FI921428L (fi) 1992-04-01
IL98988A0 (en) 1992-07-15
AU8304491A (en) 1992-03-02
CA2066174A1 (en) 1992-02-03
NZ239204A (en) 1993-11-25
GR3024111T3 (en) 1997-10-31
RU2093519C1 (ru) 1997-10-20
YU131991A (sh) 1994-05-10
NO301480B1 (no) 1997-11-03
DE69125810T2 (de) 1997-08-07
PT98544A (pt) 1992-06-30
DE69125810D1 (de) 1997-05-28
EP0495049A1 (en) 1992-07-22
HU212671B (en) 1996-09-30
HUT64564A (en) 1994-01-28
CN1033810C (zh) 1997-01-15
IE912729A1 (en) 1992-02-12
CZ286237B6 (cs) 2000-02-16
NO921236D0 (no) 1992-03-30
MY107334A (en) 1995-11-30
ATE152122T1 (de) 1997-05-15
FI921428A7 (fi) 1992-04-01
DK0495049T3 (da) 1997-08-25
KR100191697B1 (ko) 1999-06-15
ZA916026B (en) 1992-04-29
KR920702371A (ko) 1992-09-03
EP0495049B1 (en) 1997-04-23
WO1992002539A1 (en) 1992-02-20
CS236291A3 (en) 1992-02-19
FI921428A0 (fi) 1992-04-01
IL98988A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
NO921236D0 (no) Fremgangsmaate for enzymatisk fremstilling av basisk fibroblastfaktor
DE69020794D1 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
DE69938435D1 (de) Niedrigallergene Proteinvarianten
ES2176456T3 (es) Procedimiento de preparacion de un compuesto inhibidor del vih proteasa.
DE59409434D1 (de) Verfahren zur Herstellung von Hydroxyphenyl-1,3,5-Triazinen
CA2232240A1 (en) Peptide for inhibiting growth of smooth muscle cells
DE59402292D1 (de) Verfahren zur Herstellung von 1,3,5-Triazinen
WO1995015161A3 (de) Arzneimittel zur behandlung der herzinsuffizienz
CA2035917A1 (en) Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
ES2147233T3 (es) Procedimiento de realizacion de motivos sobre objetos, especialmente articulos de ceramica.
SE9000793D0 (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
DE68924423D1 (de) Supraleitende bi-sr-ca-cu oxid-zusammensetzungen und verfahren zur herstellung.
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
FR2708603B1 (fr) Procédé de préparation d'hydroperoxyde de cumène.
DE59805677D1 (de) Froststabilisierung von wässrigen überzugsmitteln durch frostschutzproteine
IT9045744A0 (it) Procedimento per la fabbricazione di rivestimenti decorativi per i mobili d'arredamento
IT8519829A0 (it) Procedimento di preparazione di acido trifluoroacetico da triclorotrifluoroetano.
DE59300999D1 (de) Verfahren zur Herstellung von N-Hydroxy-N'-diazeniumoxiden.
DE58906998D1 (de) Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin.
DE59101638D1 (de) Verfahren zur Herstellung von Alkaliphosphatlösungen.
MY114151A (en) Analogs of thymosin
DE59101321D1 (de) Verfahren zur Herstellung von Aminoarylsulfonsäuren.
TH39843A (th) อะนาลอคของโทโมซิน อัลฟา1
ATE38252T1 (de) Verfahren zur herstellung von hochverschleissfesten titannitrid-schichten.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2001